Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003.

Volume: 111, Issue: 3
Published: Nov 1, 2021
Abstract
Purpose/Objective(s) null To determine if hypofractionated post-operative prostate bed radiotherapy (HYPORT) does not increase patient-reported genitourinary (GU) or gastrointestinal (GI) toxicity over conventionally fractionated post-operative radiotherapy (COPORT). null null null Materials/Methods null Eligibility criteria were: 1) an undetectable PSA ( null null null Results null Between July 2017 and July 2018, 298 patients were screened and...
Paper Details
Title
Primary Endpoint Analysis of a Randomized Phase III Trial of Hypofractionated vs. Conventional Post-Prostatectomy Radiotherapy: NRG Oncology GU003.
Published Date
Nov 1, 2021
Volume
111
Issue
3
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.